Zhijian Xu (徐志建)

Zhijian Xu (徐志建)

Shanghai Institute of Materia Medica - Shanghai / China
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4600642
上海药物研究所
person_outline Zhijian Xu (徐志建)'s MOST POPULAR ARTICLES
1-) Halogen bond: its role beyond drug–target binding affinity for drug discovery and developmentZ Xu, Z Yang, Y Liu, Y Lu, K Chen, W ZhuJournal of chemical information and modeling 54 (1), 69-78, 20143862014
2-) Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free …Z Xu, C Peng, Y Shi, Z Zhu, K Mu, X Wang, W ZhuBioRxiv, 2020.01. 27.921627, 20203262020
3-) Halogen bonding for rational drug design and new drug discoveryY Lu, Y Liu, Z Xu, H Li, H Liu, W ZhuExpert opinion on drug discovery 7 (5), 375-383, 20123152012
4-) SARS-CoV-2 Omicron RBD shows weaker binding affinity than the currently dominant Delta variant to human ACE2L Wu, L Zhou, M Mo, T Liu, C Wu, C Gong, K Lu, L Gong, W Zhu, Z XuSignal transduction and targeted therapy 7 (1), 8, 20222342022
5-) Utilization of halogen bond in lead optimization: a case study of rational design of potent phosphodiesterase type 5 (PDE5) inhibitorsZ Xu, Z Liu, T Chen, TT Chen, Z Wang, G Tian, J Shi, X Wang, Y Lu, X Yan, ...Journal of medicinal chemistry 54 (15), 5607-5611, 20111372011